CoChat

17(R)‐resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception

Open access
Bang, S, Yoo, S, Yang, TJ, Cho, H, Hwang, SW · 2012 · British Journal of Pharmacology
Cited by 148

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND PURPOSE Transient receptor potential ion channel vanilloid 3 (TRPV3) is expressed in skin keratinocytes and plays an important role in thermal and chemical nociceptions in the periphery. The presence of TRPV3 inhibitors would improve our understanding of TRPV3 function and help to develop receptor‐specific analgesics. However, little is known about physiological substances that specifically inhibit TRPV3 activity. Here, we investigated whether 17(R)‐resolvin D1 (17R‐RvD1), a naturally occurring pro‐resolving lipid specifically affects TRPV3 activity. EXPERIMENTAL APPROACH We examined the effect of 17R‐RvD1 on sensory TRP channels using Ca 2+ imaging and whole cell electrophysiology experiments in a HEK cell heterologous expression system, cultured sensory neurons and keratinocytes. We also examined changes in sensory TRP agonist‐specific acute licking/flicking or flinching behaviours and mechanical and thermal pain behaviours using Hargreaves, Randall‐Selitto and von Frey assay systems in the absence and presence of inflammation. KEY RESULTS We showed that 17R‐RvD1 specifically suppresses TRPV3‐mediated activity at nanomolar and micromolar concentrations. The voltage‐dependence of TRPV3 activation by camphor was shifted rightwards by 17R‐RvD1, which indicates its inhibitory mechanism is as a result of a shift in voltage‐dependence. Consistently, TRPV3‐specific acute pain behaviours were attenuated by locally injected 17R‐RvD1. Moreover, the administration of 17R‐RvD1 significantly reversed the thermal hypersensitivity that occurs during an inflammatory response. Knockdown of epidermal TRPV3 blunted these antinociceptive effects of 17R‐RvD1. CONCLUSIONS AND IMPLICATIONS 17R‐RvD1 is a novel natural inhibitory substance specific for TRPV3. The results of our behavioural studies suggest that 17R‐RvD1 has acute analgesic potential via TRPV3‐specific mechanisms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2011.01568.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Guide to receptors and channels (GRAC), 5th edition

    Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947 · cited 1×

    “All drug/molecular target nomenclature used here conforms to the British Journal of Pharmacology Guide to Receptors and Channels (Alexander et al., 2011).”
    Method
  • Resolvins

    Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650 · cited 1×

    “A member of docosahexaenoic acidderived series of resolvins, 17(R)-resolvin D1 (17R-RvD1) was discovered in mammalian tissues (Serhan et al., 2002).”
    Background
  • Lipid mediator class switching during acute inflammation: signals in resolution

    Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453 · cited 2×

    “mostly composed of w-6-derived mediators, and by contrast, w-3-derived mediators contribute to the resolution of inflammation in the late stage (Levy et al., 2001).”
    Background

Cited by

See all 148

Metadata

Authors
Bang, S., Yoo, S., Yang, T., Cho, H., & Hwang, S.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2012-01-10
Volume
165
Issue
3
Pages
683-692
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1528324433
Cited by
148
References
3
FWCI
6.44
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.